Documentos relacionados

1. Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura.
2. Successful Treatment With Bortezomib for Refractory and Complicated Acquired Thrombotic Thrombocytopenic Purpura in an Adolescent Girl.
3. Upfront rituximab therapy for thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a case-based review.
4. Mind and matter: The neurological complications of thrombotic thrombocytopenic purpura.
5. Combination regimens containing daratumumab for initial diagnosed acquired thrombotic thrombocytopenic purpura.
6. Effectiveness and safety of caplacizumab in acquired thrombotic thrombocytopenic purpura: health technology assessment and classification according to the methodology established in Colombia.
7. Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab.
8. Complement activation and renal dysfunction in patients with acquired thrombotic thrombocytopenic purpura.
9. Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.
10. Real-world experience and considerations on concomitant caplacizumab and anticoagulation in thrombotic thrombocytopenic purpura.